Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Alzheimer Patients and the Snoezelen Program

Phase 1

Completed

Conditions: Dementia

Interventions: Other: Snoezelen Room
Other: Control

First Posted Date: 2007-10-24

Last Posted Date: 2015-12-16

Lead Sponsor: Queen's University

Target Recruit Count: 18

Registration Number: NCT00548951

Locations: 🇨🇦
Rideaucrest Home, Kingston, Ontario, Canada

Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole

Phase 3

Terminated

Conditions: Gastric Acid

Interventions: Drug: Esomeprazole first
Drug: Generic omeprazole first

First Posted Date: 2007-10-11

Last Posted Date: 2018-07-20

Lead Sponsor: Queen's University

Target Recruit Count: 20

Registration Number: NCT00542347

Locations: 🇨🇦
Hotel Dieu Hospital, Kingston, Ontario, Canada

Low Dose Spinal Bupivacaine for Total Knee Replacement and Recovery Room Wait Time

Not Applicable

Completed

Conditions: Spinal Anesthesia
Total Knee Arthroplasty

Interventions: Drug: Low dose bupivicaine in spinal anesthetic
Drug: Standard dose bupivacaine in spinal anesthetic

First Posted Date: 2007-10-01

Last Posted Date: 2009-04-17

Lead Sponsor: Queen's University

Target Recruit Count: 140

Registration Number: NCT00537472

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Phase 1

Terminated

Conditions: Chronic Pain Syndrome
Prostatitis

Interventions: Drug: Botox

First Posted Date: 2007-09-14

Last Posted Date: 2019-03-25

Lead Sponsor: Queen's University

Target Recruit Count: 7

Registration Number: NCT00529386

Locations: 🇨🇦
Centre for Advanced Urological Research, Kingston, Ontario, Canada

Effects of Exercise Modality on Abdominal Obesity and Health Risk Factors in Older Men and Women

Not Applicable

Completed

Conditions: Abdominal Obesity

Interventions: Other: Resistance Exercise (RE)
Other: Aerobic Exercise (AE)
Other: Resistance and Aerobic Exercise (RAE)

First Posted Date: 2007-08-27

Last Posted Date: 2008-04-22

Lead Sponsor: Queen's University

Target Recruit Count: 145

Registration Number: NCT00520858

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Efficacy of an Occupational Time Use Intervention for People With Serious Mental Illness

Phase 1

Completed

Conditions: Serious Mental Illness

Interventions: Behavioral: Occupational Time Use Intervention

First Posted Date: 2007-08-24

Last Posted Date: 2015-09-02

Lead Sponsor: Queen's University

Target Recruit Count: 18

Registration Number: NCT00520728

An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients

Phase 4

Completed

Conditions: Depression
Bipolar Disorder
Depressive Disorder

Interventions: Drug: Olanzapine
Drug: Placebo

First Posted Date: 2007-08-24

Last Posted Date: 2015-12-16

Lead Sponsor: Queen's University

Target Recruit Count: 27

Registration Number: NCT00520507

Locations: 🇨🇦
Queen's University, Providence Care-Mental Health Services, Kingston, Ontario, Canada

Methylene Blue in Sepsis: A Randomized Controlled Trial

Not Applicable

Withdrawn

Conditions: Sepsis

Interventions: Drug: methylene blue

First Posted Date: 2007-06-14

Last Posted Date: 2008-05-29

Lead Sponsor: Queen's University

Registration Number: NCT00486174

Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty

Not Applicable

Completed

Conditions: Pseudoexfoliation Glaucoma
Primary Open Angle Glaucoma

Interventions: Drug: prednisolone 1%
Drug: ketorolac 0.5%
Drug: Artificial Tears (Methyl cellulose drops)

First Posted Date: 2007-06-12

Last Posted Date: 2015-09-23

Lead Sponsor: Queen's University

Target Recruit Count: 120

Registration Number: NCT00485108

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 3

Completed

Conditions: Brain and Central Nervous System Tumors

Interventions: Genetic: DNA methylation analysis
Drug: temozolomide
Procedure: quality-of-life assessment
Radiation: Radiation

First Posted Date: 2007-06-05

Last Posted Date: 2023-08-22

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 562

Registration Number: NCT00482677

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦
BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada

and more 19 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy